Published in Neurochem Pathol on January 01, 1985
Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One (2009) 1.36
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol (2009) 1.13
Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One (2012) 1.01
The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95
Glutamatergic denervation in Alzheimer's disease--a cautionary note. J Neurol Neurosurg Psychiatry (1987) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet (1989) 4.57
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J (1978) 3.59
More general physicians or specialists? J R Coll Physicians Lond (1995) 2.92
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
Staging and natural history of cerebrovascular pathology in dementia. Neurology (2012) 2.61
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 2.47
Prevalence rates of dementia in an ageing population: are low rates due to the use of insensitive instruments? Age Ageing (1990) 2.45
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet (1998) 2.06
Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr (1987) 2.04
Stroke after a visit to the hairdresser. Lancet (1997) 2.03
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology (1999) 2.00
Necropsy evidence of central cholinergic deficits in senile dementia. Lancet (1977) 1.97
Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res (2000) 1.93
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Letter: Unusual cardiac and neurological reactions to narcotics. Lancet (1973) 1.90
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res (1981) 1.85
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci (1977) 1.83
Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol (1978) 1.82
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Radiation myelitis of the dorsolumbar spinal cord. Radiology (1969) 1.64
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Three further cases of Lyme disease. Br Med J (Clin Res Ed) (1987) 1.55
Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health (1995) 1.53
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med (1992) 1.49
Physical mapping around the Alzheimer disease locus on the proximal long arm of chromosome 21. Am J Hum Genet (1990) 1.49
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry (2001) 1.44
Cortical neurogenesis in adult rats after reversible photothrombotic stroke. J Cereb Blood Flow Metab (2000) 1.43
Axillary hyperhidrosis: a 5-year review of treatment efficacy and recurrence rates using a new arthroscopic shaver technique. Plast Reconstr Surg (2007) 1.40
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Multiple sclerosis presenting solely with bladder disturbance. Br J Urol (1997) 1.39
Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology (2007) 1.38
Computerised tomography scans of the head in a district general hospital. J R Coll Physicians Lond (1997) 1.38
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry (1985) 1.31
Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke (2001) 1.30
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol (2006) 1.29
Lyme disease: prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers. Lancet (1989) 1.29
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol (1994) 1.28
Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions (1986) 1.28
An evaluation of lymphadenectomy in the treatment of malignant testicular germ cell neoplasms. J Urol (1969) 1.26
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci (1991) 1.24
Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res (1997) 1.23
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm (1985) 1.21
The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry (1994) 1.18
An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology (1994) 1.18
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology (1999) 1.18
Enigmatic dyspnoea: an unusual presentation of motor-neurone disease. Lancet (1982) 1.17
Anti-inflammatory activity of Euphorbia acaulis Roxb. J Ethnopharmacol (1984) 1.16
Clinically and neuropathologically distinct form of dementia in the elderly. Lancet (1989) 1.16
Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum Genet (2006) 1.16
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype. J Biol Chem (2001) 1.16
Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med (1991) 1.14
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett (1982) 1.14
Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol (1989) 1.13
Vaccine related poliomyelitis in non-immunised relatives and household contacts. Br Med J (Clin Res Ed) (1987) 1.12
Amyloid precursor protein gene mutation in early-onset Alzheimer's disease. Lancet (1991) 1.12
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) (1981) 1.11
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging (1987) 1.10
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res (2007) 1.10
Case-Control study of the extended tau gene haplotype in Parkinson's disease. Ann Neurol (2001) 1.09
The metabolism of glucose 6-phosphate by mammalian cerebral cortex in vitro. Biochem J (1971) 1.09
A retrospective survey of proven cases of tuberculous meningitis in the Northern Region, 1970-1980. J R Coll Physicians Lond (1983) 1.08
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci Lett (1997) 1.08
Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res (2004) 1.08
Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett (1980) 1.06
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci (1981) 1.05
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett (1983) 1.05
The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett (1982) 1.04
Experimental stroke and neuroprotection in the aging rat brain. Stroke (1995) 1.04
Mean intracranial pressure monitoring by a non-invasive audiological technique: a pilot study. J Neurol Neurosurg Psychiatry (1989) 1.04
Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann N Y Acad Sci (2004) 1.03
Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect (1990) 1.03
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol (2004) 1.03
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience (1998) 1.02